PRODRUGS OF FULVESTRANT

• 1. 呼气中令人不快的臭气成分的含有水平的推定方法、呼气中令人不快的臭气成分的含有水平的推定装置、程序和口臭护理方法 [P] . 中国专利： CN111527405A . 2020-08-11
• 2. 含有植物提取物的颗粒的制造方法、抑制由含有植物提取物的颗粒产生微粉的方法、以及抑制含有植物提取物的颗粒的令人不快的味道的方法 [P] . 中国专利： CN112839527A . 2021-05-25
• 3. PRODRUGS OF FULVESTRANT [P] . EP3801553A2 . 2021-04-14

  机译： 乌利特的前药

• 4. PRODRUGS OF FULVESTRANT [P] . WO2021100029A3 . 2021-07-01

  机译： 乌利特的前药

• 5. PRODRUGS OF FULVESTRANT [P] . US2021253626A1 . 2021-08-19

  机译： 乌利特的前药

• 1. New insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase (MGMT)in human breast cancer cells:Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy [J] . Ameya Paranjpe, Nathan I.Bailey, Santhi Konduri, 生物医学研究杂志（英文版） . 2016,第005期
• 2. New insights into estrogenic regulation of O~6-methylguanine DNA-methyltransferase(MGMT) in human breast cancer cells:Co-degradation of ER-α and MGMT proteins by fulvestrant or O~6-benzylguanine indicates fresh avenues for therapy [J] . Ameya Paranjpe, Nathan I.Bailey, Santhi Konduri, 生物医学研究杂志：英文版 . 2016,第005期
• 3. New insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase （MGMT） in human breast cancer cells： Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy [J] . Ameya Paranjpe, Nathan I. Bailes, Santhi Konduri, 生物医学研究杂志：英文版 . 2016,第005期
• 4. Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant [J] . Gary Schwartz, Kevin Shee, Bianca Romo, The oncologist . 2021,第6期
• 5. Liquid chromatography tandem mass spectrometry method for determination of fulvestrant in rat plasma and its application to pharmacokinetic studies of a novel fulvestrant microcrystal [J] . Guangyi Leng, Yanhua Zuo, Jiahui Hu, Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences . 2020,第10期
• 6. Factors associated with prolonged post-recurrence survival in patients with postmenopausal estrogen receptor-positive breast cancer taking fulvestrant: A follow-up data of the JBCRG-C06 Safari study factors associated with prolonged post-recurrence survival in patients with postmenopausal estrogen receptor-positive breast cancer taking fulvestrant: A follow-up data of the JBCRGC-06 Safari study [J] . Intelligence: A Multidisciplinary Journal . 2020,第期
• 7. PRODRUG TARGETING USING HYDROLASES : BIPHENYL HYDROLASE-LIKE (BPHL) HYDROLYZES VALACYCLOVIR, AN ESTER PRODRUG OF ACYCLOVIR [C] . Insook Kim, Xiaoyan Chu, Kyung-Dall Lee, Proceedings of the 29th Annual Meeting of the Controlled Release Society . 2002
• 8. Different epigenetic mechanisms of ERa implicated in the fate of fulvestrant-resistant breast cancer [D] . Tsuboi Kouki 2019
• 9. A dual role of miR-22 modulated by RelA/p65 in resensitizing fulvestrant-resistant breast cancer cells to fulvestrant by targeting FOXP1 and HDAC4 and constitutive acetylation of p53 at Lys382 [O] . Bo Wang, Dongping Li, Jody Filkowski, 2018
• 10. Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib ( MLN9708 ) and Fulvestrant in Advanced ER + Breast Cancer Progressing on Fulvestrant [O] . Gary Schwartz, Kevin Shee, Bianca Romo, 2021
• 11. Pancratistatin Cyclic Phosphate Prodrugs an Phenpanstatin Cyclic Phosphate Prodrugs. [R] . Pettit, G. R., Melody, N. 2004

• 1. MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy [J] . . 中国药理学通报 . 2015,第B11期
• 2. GP88 (Progranulin) Confers Fulvestrant (Faslodex, ICI 182,780) Resistance to Human Breast Cancer Cells [J] . Wisit Tangkeangsirisin ,Ginette Serrero . 乳腺癌（英文） . 2014,第3期
• 3. 《基本安全——个人求生》课程的综合恐惧症及其克服——兼谈航海恐惧症的克服 [C] . 陈金辉 . 中国航海学会航海心理学专业委员会2017年学术年会 . 2017
• 4. 从原始恐惧到社会恐惧——论霍布斯的恐惧观及其演变 [A] . 王勇刚 . 2017